Raymond James Trust N.A. Cerus Corp Transaction History

Raymond James Trust N.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.07 $12,000 - $24,560	-8,000 Reduced 42.11%	11,000 $17,000
Q2 2023 Aug 15, 2023	SELL	$1.79 - $2.9 $87,710 - $142,100	-49,000 Reduced 72.06%	19,000 $47,000
Q4 2022 Feb 02, 2023	SELL	$3.38 - $4.22 $81,120 - $101,280	-24,000 Reduced 26.09%	68,000 $248,000
Q1 2021 May 03, 2021	BUY	$5.68 - $7.87 $56,800 - $78,700	10,000 Added 12.2%	92,000 $553,000
Q4 2020 Jan 13, 2021	BUY	$5.25 - $8.56 $89,250 - $145,520	17,000 Added 26.15%	82,000 $567,000
Q3 2020 Oct 14, 2020	BUY	$5.78 - $7.47 $57,800 - $74,700	10,000 Added 18.18%	65,000 $407,000
Q1 2020 Apr 17, 2020	BUY	$2.87 - $5.49 $86,100 - $164,700	30,000 Added 120.0%	55,000 $256,000
Q3 2019 Oct 24, 2019	BUY	$4.86 - $6.05 $14,580 - $18,150	3,000 Added 13.64%	25,000 $129,000
Q2 2019 Jul 15, 2019	BUY	$4.51 - $6.6 $36,080 - $52,800	8,000 Added 57.14%	22,000 $124,000
Q4 2018 Jan 29, 2019	BUY	$4.89 - $7.16 $68,460 - $100,240	14,000 New	14,000 $71,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $294M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

Stay updated on Raymond James Trust N.A. with notifications on news.